mitomycin has been researched along with Gasser Syndrome in 68 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient receiving the antitumor agent mitomycin C (MMC) in combination with 5-fluorouracil and adriamycin because of adenocarcinoma of Vater's papilla manifested hemolytic-uremic syndrome (HUS) after five cycles of 5-fluorouracil-adriamycin-MMC combination chemotherapy." | 8.77 | Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy. ( Binsack, T; Mergenthaler, HG; Wilmanns, W, 1988) |
| "We have studied the ability of the plasma to induce aggregation of both homologous and heterologous platelets in four patients with hemolytic-uremic syndrome (HUS) associated with chemotherapy with mitomycin C (MMC)." | 7.68 | Investigation of plasma von Willebrand factor and circulating platelet aggregating activity in mitomycin C-related hemolytic-uremic syndrome. ( Castillo, R; Monteagudo, J; Ordinas, A; Pereira, A; Reverter, JC; Roig, S, 1990) |
| "A thrombotic microangiopathy resembling the hemolytic uremic syndrome was diagnosed in 12 patients with adenocarcinoma, in whom the tumor was in complete or near-complete remission after treatment with mitomycin C-containing drug regimens." | 7.67 | Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. ( Cantrell, JE; Phillips, TM; Schein, PS, 1985) |
| "Mitomycin C is a powerful antineoplastic agent." | 5.31 | Erythropoietin is beneficial in mitomycin-induced hemolytic-uremic syndrome. ( Catalano, C; Fabbian, F; Gianesini, C, 2002) |
| "A comparison of patients receiving combination chemotherapy with mitomycin C, mitozantrone and methotrexate (3M) with and without tamoxifen for treatment of primary breast cancer indicates an increased risk of anaemia (P < 0." | 5.07 | A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome. ( Ashley, SE; Luckit, J; Montes, A; O'Brien, ME; Powles, TJ; Treleaven, J, 1993) |
| "A patient receiving the antitumor agent mitomycin C (MMC) in combination with 5-fluorouracil and adriamycin because of adenocarcinoma of Vater's papilla manifested hemolytic-uremic syndrome (HUS) after five cycles of 5-fluorouracil-adriamycin-MMC combination chemotherapy." | 4.77 | Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy. ( Binsack, T; Mergenthaler, HG; Wilmanns, W, 1988) |
| "A patient with mitomycin-associated hemolytic-uremic syndrome received SPA treatments after her ACE inhibitor, lisinopril, was held." | 3.71 | Hypotensive reaction during staphylococcal protein A column therapy in a patient with anomalous degradation of bradykinin and Des-Arg9-bradykinin after contact activation. ( Adam, A; Eastlund, T; Hammerschmidt, D; Koenigbauer, U; Lepage, Y; Molinaro, G, 2002) |
| "A 50-year-old woman treated for breast cancer with mitomycin C developed severe hypertension, followed by deep coma 3 days later." | 3.71 | Hemolytic uremic syndrome with intracranial hemorrhage following mitomycin C administration. ( Katayama, Y; Kitamura, H; Komaba, Y; Nishiyama, Y, 2001) |
| "A 63-year-old male had undergone combination chemotherapy including adriamycin, cisplatin, mitomycin C, 5-fluorouracil and vindesine for six months for double cancer of esophagus and stomach." | 3.68 | [Chemotherapy-associated hemolytic uremic syndrome--a case report]. ( Kanamaru, R; Kikuchi, H, 1992) |
| "We have studied the ability of the plasma to induce aggregation of both homologous and heterologous platelets in four patients with hemolytic-uremic syndrome (HUS) associated with chemotherapy with mitomycin C (MMC)." | 3.68 | Investigation of plasma von Willebrand factor and circulating platelet aggregating activity in mitomycin C-related hemolytic-uremic syndrome. ( Castillo, R; Monteagudo, J; Ordinas, A; Pereira, A; Reverter, JC; Roig, S, 1990) |
| "A thrombotic microangiopathy resembling the hemolytic uremic syndrome was diagnosed in 12 patients with adenocarcinoma, in whom the tumor was in complete or near-complete remission after treatment with mitomycin C-containing drug regimens." | 3.67 | Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. ( Cantrell, JE; Phillips, TM; Schein, PS, 1985) |
| "In this large pooled analysis, we found MMC, when capped at a cumulative dose of 36 mg/m(2), to be safe and tolerable in combination with capecitabine or irinotecan with no reportable cases of TTP/HUS." | 2.46 | Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials. ( Arce-Lara, C; Bekaii-Saab, T; Cataland, S; Kraut, E; Ntukidem, N; Otterson, GA, 2010) |
| "Drug-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome (TTP/HUS) has been recognized for several years." | 2.43 | Drug-induced thrombotic microangiopathy. ( Bennett, C; Zakarija, A, 2005) |
| "A 42-year-old female with stage III gastric cancer underwent radical gastrectomy and was given mitomycin-C at 10 mg/m2 intravenously every four weeks as adjuvant therapy." | 2.40 | Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review. ( Chen, LT; Chen, YM; Liu, JM; Liu, SM; Whang-Peng, J; Wu, DC; Yang, S, 1997) |
| "Mitomycin (MMC) was part of the treatment regimen in 84 patients; all but nine received a cumulative dose greater than 60 mg." | 2.38 | Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. ( Arbus, M; Chiazze, L; Erickson, B; Keller, J; Korec, S; Lesesne, JB; Rothschild, N; Schein, PS; Sisk, R; Woolley, PV, 1989) |
| "Mitomycin-C (MMC) is a first-line therapy for anal squamous cell carcinoma (ASCC), and it continues to be used for several other indications." | 1.37 | Mitomycin--C-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: cumulative toxicity of an old drug in a new era. ( Chu, E; El-Ghazal, R; Marks, P; Podoltsev, N; Saif, MW, 2011) |
| "In addition, the patient had anaphylactoid reactions at the onset of immunoadsorption similar to first-use dialysis reactions that correlated with increases in complement 3a and 5a, interleukin-1 (IL-1), IL-6, and tumor necrosis factor levels." | 1.32 | The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndrome. ( Braden, GL; Hetzel, PC; Kimmel, PL; Mistry, B; Phillips, TM, 2004) |
| "Mitomycin C is a powerful antineoplastic agent." | 1.31 | Erythropoietin is beneficial in mitomycin-induced hemolytic-uremic syndrome. ( Catalano, C; Fabbian, F; Gianesini, C, 2002) |
| "We examined 159 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in Japan." | 1.30 | Outcome of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in Japan. ( Ihara, T; Kakisita, E; Minami, N; Mori, Y; Omine, M; Shiku, H; Tamaki, S; Wada, H, 1999) |
| "Hyporeninemic hypoaldosteronism was transiently seen in case 2." | 1.29 | Long-term follow-up of mitomycin C nephropathy. ( Ikeda, K; Motoo, Y; Ohta, H; Okai, T; Sawabu, N; Takemori, Y; Yokoyama, H, 1994) |
| " The case history reported here is discussed in relation to dose and scheduling of mitomycin C, and a safe maximum dosage is suggested." | 1.28 | Cancer-associated hemolytic-uremic syndrome with spontaneous resolution. A case report. ( Abdolrahimzadeh, S; Barone, C; Franchi, F; Gozzer, M; Seminara, P, 1991) |
| "Mitomycin C (MMC) is a cytotoxic agent that may induce a hemolytic uremic syndrome (HUS) with severe renal insufficiency." | 1.27 | Recovery from mitomycin C-induced hemolytic uremic syndrome. A case report. ( Boven, E; Pinedo, HM; van der Meulen, J; Verwey, J, 1984) |
| "Mitomycin C (MMC) has been known to be nephrotoxic since 1971." | 1.27 | Mitomycin C-induced renal toxicity, a dose-dependent side effect? ( de Vries, J; Pinedo, HM; Verwey, J, 1987) |
| "Mitomycin C was administered in successive cures at a cumulative dose higher than 50 mg/m2." | 1.27 | [Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology]. ( Alix, JL; Bayle, F; Cordonnier, D; Couderc, P; Vert-Pré, FC, 1985) |
| " The severity of the glomerular, vascular, and tubular lesions correlated with the total dosage of MMC received." | 1.27 | Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases. ( Bettez, P; Giroux, L, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (41.18) | 18.7374 |
| 1990's | 21 (30.88) | 18.2507 |
| 2000's | 15 (22.06) | 29.6817 |
| 2010's | 4 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amran, MY | 1 |
| Fujii, J | 1 |
| Kolling, GL | 1 |
| Villanueva, SY | 1 |
| Kainuma, M | 1 |
| Kobayashi, H | 1 |
| Kameyama, H | 1 |
| Yoshida, S | 1 |
| Ahlgren, J | 1 |
| Patel, N | 1 |
| Simmens, S | 1 |
| Akin, E | 1 |
| Bishop, C | 1 |
| Kirkel, D | 1 |
| Siegel, P | 1 |
| Schuck, S | 1 |
| Guebre-Xabiher, H | 1 |
| Siegel, R | 1 |
| Camp-Sorrell, D | 1 |
| Ntukidem, N | 1 |
| Arce-Lara, C | 1 |
| Otterson, GA | 1 |
| Kraut, E | 1 |
| Cataland, S | 1 |
| Bekaii-Saab, T | 1 |
| El-Ghazal, R | 1 |
| Podoltsev, N | 1 |
| Marks, P | 1 |
| Chu, E | 1 |
| Saif, MW | 1 |
| Hofheinz, RD | 1 |
| Hartung, G | 1 |
| Samel, S | 1 |
| Hochhaus, A | 1 |
| Pichlmeier, U | 1 |
| Post, S | 1 |
| Hehlmann, R | 1 |
| Queisser, W | 1 |
| Gundappa, RK | 1 |
| Sud, K | 1 |
| Kohli, HS | 1 |
| Gupta, KL | 1 |
| Joshi, K | 1 |
| Sakhuja, V | 1 |
| Molinaro, G | 1 |
| Adam, A | 1 |
| Lepage, Y | 1 |
| Hammerschmidt, D | 1 |
| Koenigbauer, U | 1 |
| Eastlund, T | 1 |
| Ritchie, JM | 1 |
| Wagner, PL | 1 |
| Acheson, DW | 2 |
| Waldor, MK | 1 |
| Zeller, G | 1 |
| Wandel, E | 1 |
| Schwarting, A | 1 |
| Steffens, F | 1 |
| Mistry, B | 1 |
| Kimmel, PL | 1 |
| Hetzel, PC | 1 |
| Phillips, TM | 2 |
| Braden, GL | 1 |
| Zakarija, A | 1 |
| Bennett, C | 1 |
| Shah, R | 1 |
| Beem, E | 1 |
| Sautina, L | 1 |
| Zharikov, SI | 1 |
| Segal, MS | 1 |
| Kasper, S | 1 |
| Neurath, MF | 1 |
| Huber, C | 1 |
| Theobald, M | 1 |
| Scharrer, I | 1 |
| Willie, GR | 1 |
| Levy, SM | 1 |
| Michaels, RS | 1 |
| Zirkin, RM | 1 |
| Crocker, J | 1 |
| Jones, EL | 1 |
| Boven, E | 3 |
| Pinedo, HM | 5 |
| van Spreeuwel, JP | 1 |
| Hemrika, MH | 1 |
| de Maat, CE | 1 |
| Nadorp, JH | 1 |
| Loprinzi, CL | 1 |
| Verwey, J | 2 |
| van der Meulen, J | 1 |
| Ito, K | 1 |
| Komatsu, Y | 1 |
| O'Brien, ME | 2 |
| Casey, S | 1 |
| Treleaven, J | 3 |
| Powles, TJ | 2 |
| Motoo, Y | 1 |
| Sawabu, N | 1 |
| Ikeda, K | 1 |
| Takemori, Y | 1 |
| Ohta, H | 1 |
| Okai, T | 1 |
| Yokoyama, H | 1 |
| Shirakawa, K | 1 |
| Morita, S | 1 |
| Tojo, M | 1 |
| Tsuda, M | 1 |
| Uchida, R | 1 |
| Mimoto, H | 1 |
| Hatamori, N | 1 |
| Okabayashi, Y | 1 |
| Saeki, S | 1 |
| Oimomi, M | 1 |
| Montes, A | 1 |
| Ashley, SE | 1 |
| Luckit, J | 1 |
| Terada, H | 1 |
| Tohda, S | 1 |
| Shiigai, T | 1 |
| Jibiki, M | 1 |
| Aoi, T | 1 |
| Ueda, Y | 1 |
| Kawasaki, T | 1 |
| Kurokawa, H | 1 |
| Nara, N | 1 |
| Ellis, PA | 1 |
| Luckitt, J | 1 |
| Smith, IE | 1 |
| Groff, JA | 1 |
| Kozak, M | 1 |
| Boehmer, JP | 1 |
| Demko, TM | 1 |
| Diamond, JR | 1 |
| Wu, DC | 1 |
| Liu, JM | 1 |
| Chen, YM | 1 |
| Yang, S | 1 |
| Liu, SM | 1 |
| Chen, LT | 1 |
| Whang-Peng, J | 1 |
| Schiebe, ME | 1 |
| Hoffmann, W | 1 |
| Belka, C | 1 |
| Bamberg, M | 1 |
| Borghardt, EJ | 1 |
| Kirchertz, EJ | 1 |
| Marten, I | 1 |
| Fenchel, K | 1 |
| Mori, Y | 2 |
| Wada, H | 1 |
| Tamaki, S | 1 |
| Minami, N | 1 |
| Shiku, H | 1 |
| Ihara, T | 1 |
| Omine, M | 1 |
| Kakisita, E | 1 |
| Duvic, C | 1 |
| Sarret, D | 1 |
| Coutant, G | 1 |
| Herody, M | 1 |
| Didelot, F | 1 |
| Nedelec, G | 1 |
| Arola, O | 1 |
| Aho, H | 1 |
| Asola, M | 1 |
| Kauppila, M | 1 |
| Nikkanen, V | 1 |
| Voipio-Pulkki, LM | 1 |
| Nishiyama, Y | 1 |
| Komaba, Y | 1 |
| Kitamura, H | 1 |
| Katayama, Y | 1 |
| Medina, PJ | 1 |
| Sipols, JM | 1 |
| George, JN | 1 |
| Catalano, C | 1 |
| Gianesini, C | 1 |
| Fabbian, F | 1 |
| Kikuchi, H | 1 |
| Kanamaru, R | 1 |
| Seminara, P | 1 |
| Franchi, F | 1 |
| Abdolrahimzadeh, S | 1 |
| Gozzer, M | 1 |
| Barone, C | 1 |
| Monteagudo, J | 1 |
| Pereira, A | 1 |
| Roig, S | 1 |
| Reverter, JC | 1 |
| Ordinas, A | 1 |
| Castillo, R | 1 |
| Poch, E | 1 |
| Almirall, J | 2 |
| Nicolas, JM | 2 |
| Torras, A | 2 |
| Revert, L | 1 |
| Villalta, J | 1 |
| González-Clemente, JM | 1 |
| Antúnez, E | 1 |
| Bosch, J | 1 |
| Urbano-Márquez, A | 1 |
| Anai, H | 1 |
| Okada, Y | 1 |
| Okubo, K | 1 |
| Korenaga, D | 1 |
| Maehara, Y | 1 |
| Sugimachi, K | 1 |
| Ohi, Y | 1 |
| Garibotto, G | 1 |
| Acquarone, N | 1 |
| Saffioti, S | 1 |
| Deferrari, G | 1 |
| Villaggio, B | 1 |
| Ferrario, F | 1 |
| Lesesne, JB | 1 |
| Rothschild, N | 1 |
| Erickson, B | 1 |
| Korec, S | 1 |
| Sisk, R | 1 |
| Keller, J | 1 |
| Arbus, M | 1 |
| Woolley, PV | 1 |
| Chiazze, L | 1 |
| Schein, PS | 2 |
| Donohue-Rolfe, A | 1 |
| Desablens, B | 1 |
| Fievet, P | 1 |
| Pruna, A | 1 |
| Claisse, JF | 1 |
| Westeel, PF | 1 |
| Tolani, M | 1 |
| Fournier, A | 1 |
| Sheldon, R | 1 |
| Slaughter, D | 1 |
| Verweij, J | 2 |
| van der Burg, ME | 1 |
| Omata, M | 1 |
| Kikuchi, M | 1 |
| Higuchi, C | 1 |
| Sanaka, S | 1 |
| Takuma, T | 1 |
| Sugino, N | 1 |
| Hostetter, AL | 1 |
| Tubbs, RR | 1 |
| Ziegler, T | 1 |
| Gephardt, GN | 1 |
| McMahon, JT | 1 |
| Schreiber, MJ | 1 |
| Wils, J | 1 |
| Grave, W | 1 |
| van Breda Vriesman, PJ | 1 |
| Jain, S | 1 |
| Seymour, AE | 1 |
| Follezou, JY | 1 |
| Baumelou, A | 1 |
| Audebert, A | 1 |
| Beaufils, H | 1 |
| Karkouche, B | 1 |
| D'Elia, JA | 1 |
| Aslani, M | 1 |
| Schermer, S | 1 |
| Cloud, L | 1 |
| Bothe, A | 1 |
| Dzik, W | 1 |
| Mergenthaler, HG | 1 |
| Binsack, T | 1 |
| Wilmanns, W | 1 |
| de Vries, J | 1 |
| de Insausti, CL | 1 |
| Gutiérrez, LE | 1 |
| van der Gaast, A | 1 |
| Planting, AS | 1 |
| Stoter, G | 1 |
| Cantrell, JE | 1 |
| Cordonnier, D | 1 |
| Vert-Pré, FC | 1 |
| Bayle, F | 1 |
| Alix, JL | 1 |
| Couderc, P | 1 |
| Guelpa, G | 1 |
| Giroux, L | 2 |
| Bettez, P | 1 |
| Chang-Poon, VY | 1 |
| Hwang, WS | 1 |
| Wong, A | 1 |
| Berry, J | 1 |
| Klassen, J | 1 |
| Poon, MC | 1 |
13 reviews available for mitomycin and Gasser Syndrome
| Article | Year |
|---|---|
Hemolytic uremic syndrome.
Topics: Adult; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antihypertensive Agents; Anus Neoplasm | 2008 |
Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Clinical Trials as Topic | 2010 |
Drug-induced thrombotic microangiopathy.
Topics: ADAM Proteins; ADAMTS13 Protein; Antibiotics, Antineoplastic; Cyclosporine; Endothelium, Vascular; F | 2005 |
[Drug induced hemolytic uremic syndrome].
Topics: Cisplatin; Cocaine; Cyclosporine; Hemolytic-Uremic Syndrome; Heparin; Humans; Mitomycin; Plasma Exch | 1993 |
[Mitomycin C associated hemolytic uremic syndrome--a case report and review of the Japanese cases].
Topics: Adult; Aged; Female; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Mitomycin; Prognosis; Sto | 1993 |
[Hemolytic-uremic syndrome].
Topics: Bacterial Toxins; Bone Marrow Transplantation; Dysentery, Bacillary; Escherichia coli; Hemolytic-Ure | 1993 |
Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Drug Administration Schedule; F | 1997 |
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Topics: Antibiotics, Antineoplastic; Clopidogrel; Cyclosporine; Hemolytic-Uremic Syndrome; Humans; Immunosup | 2001 |
[Uremic hemolytic syndrome induced by mitomycin C. Presentation of a series of 5 cases and review of the literature].
Topics: Adenocarcinoma; Aged; Female; Gastrointestinal Neoplasms; Hemolytic-Uremic Syndrome; Humans; Male; M | 1990 |
Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry.
Topics: Adenocarcinoma; Female; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Mitomycin; Mitomycins; | 1989 |
Mitomycin C-induced hemolytic uremic syndrome. Six case reports and review of the literature on renal, pulmonary and cardiac side effects of the drug.
Topics: Adult; Aged; Female; Heart; Hemolytic-Uremic Syndrome; Humans; Kidney; Lung; Male; Middle Aged; Mito | 1987 |
Hemolytic-uremic syndrome and acute renal failure in metastatic adenocarcinoma treated with mitomycin: case report and literature review.
Topics: Acute Kidney Injury; Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast N | 1987 |
Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy.
Topics: Adenocarcinoma; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasm | 1988 |
3 trials available for mitomycin and Gasser Syndrome
| Article | Year |
|---|---|
High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Do | 2002 |
A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Interact | 1993 |
Protein A-immunoadsorption in chemotherapy associated hemolytic-uremic syndrome.
Topics: Antibiotics, Antineoplastic; Hemolytic-Uremic Syndrome; Humans; Immunosorbent Techniques; Mitomycin; | 1998 |
52 other studies available for mitomycin and Gasser Syndrome
| Article | Year |
|---|---|
Proposal for effective treatment of Shiga toxin-producing Escherichia coli infection in mice.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Colon; Drugs, Chinese Herbal; Escherichia coli O157; F | 2013 |
O-MAX chemotherapy: high activity in metastatic esophagogastric adenocarcinoma and possible relation to subclinical hemolysis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycyti | 2014 |
Mitomycin--C-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: cumulative toxicity of an old drug in a new era.
Topics: Aged; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anus N | 2011 |
Mitomycin-C induced hemolytic uremic syndrome: a case report.
Topics: Adenocarcinoma; Alkylating Agents; Antibiotics, Antineoplastic; Colonic Neoplasms; Diagnosis, Differ | 2002 |
Hypotensive reaction during staphylococcal protein A column therapy in a patient with anomalous degradation of bradykinin and Des-Arg9-bradykinin after contact activation.
Topics: Acute Disease; Aminopeptidases; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Combined Ch | 2002 |
Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates.
Topics: Animals; Cattle; Cattle Diseases; Escherichia coli; Escherichia coli Infections; Escherichia coli O1 | 2003 |
[Mitomycin-induced hemolytic-uremic syndrome].
Topics: Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Hemolytic-Uremic Syndrome; Hemorrhage; Humans; | 2003 |
[Mitomycin-induced hemolytic uremia syndrome].
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Do | 2004 |
The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndrome.
Topics: Anaphylaxis; Antibiotics, Antineoplastic; Antigen-Antibody Complex; Cytokines; Female; Hemolytic-Ure | 2004 |
Mitomycin- and calcineurin-associated HUS, endothelial dysfunction and endothelial repair: a new paradigm for the puzzle?
Topics: Adenocarcinoma; Adult; Antibiotics, Antineoplastic; Antigens, CD34; Biomarkers; Burkitt Lymphoma; Ca | 2007 |
Protein A immunoadsorption therapy for refractory, mitomycin C-associated thrombotic microangiopathy.
Topics: Adult; Female; Hemolytic-Uremic Syndrome; Humans; Immunosorbent Techniques; Mitomycin; Purpura, Thro | 2007 |
Hemolytic-uremic syndrome in a patient receiving mitomycin C and 5-fluorouracil.
Topics: Adenocarcinoma, Mucinous; Aged; Colonic Neoplasms; Fluorouracil; Hemolytic-Uremic Syndrome; Humans; | 1983 |
Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Drug Therapy, Combination; Female; Fluorouracil; Hemolytic | 1983 |
Mitomycin C: interstitial pneumonitis and haemolytic-uraemic syndrome.
Topics: Adult; Female; Hemolytic-Uremic Syndrome; Humans; Mitomycin; Mitomycins; Prednisone; Pulmonary Fibro | 1983 |
Two patients suffering from interstitial pneumonitis and haemolytic-uraemic syndrome as side effects of mitomycin C therapy.
Topics: Adult; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Pulmonary Fibros | 1983 |
Two patients with a fatal haemolytic-uremic syndrome after combination therapy including mitomycin C.
Topics: Hemolytic-Uremic Syndrome; Humans; Mitomycin; Mitomycins | 1983 |
Mitomycin C-induced pulmonary and renal toxicities.
Topics: Antibiotics, Antineoplastic; Female; Hemolytic-Uremic Syndrome; Humans; Lung Diseases; Middle Aged; | 1984 |
Recovery from mitomycin C-induced hemolytic uremic syndrome. A case report.
Topics: Blood Transfusion; Female; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Mitomycin; Mitomycins; Re | 1984 |
Use of erythropoietin in the management of the haemolytic uraemic syndrome induced by mitomycin C/tamoxifen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Erythropoietin; Female; Hemolytic-Uremic Synd | 1994 |
Long-term follow-up of mitomycin C nephropathy.
Topics: Hemolytic-Uremic Syndrome; Humans; Hypoaldosteronism; Kidney Diseases; Male; Microscopy, Electron; M | 1994 |
[Three cases of drug-induced hemolytic uremic syndrome].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Fluorouracil; Gastrointest | 1996 |
Haemolytic uraemic syndrome in a patient with lung cancer: further evidence for a toxic interaction between mitomycin-C and tamoxifen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Hemolytic-Uremic Syndrome; Humans; Lung Neop | 1996 |
Endotheliopathy: a continuum of hemolytic uremic syndrome due to mitomycin therapy.
Topics: Adult; Antibiotics, Antineoplastic; Endothelium, Vascular; Hemolytic-Uremic Syndrome; Humans; Male; | 1997 |
Mitomycin C-related hemolytic uremic syndrome in cancer patients.
Topics: Adenocarcinoma; Adult; Antibiotics, Antineoplastic; Breast Neoplasms; Female; Hemolytic-Uremic Syndr | 1998 |
Outcome of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in Japan.
Topics: Adolescent; Adult; Aged; Aspirin; Bacterial Toxins; Child; Child, Preschool; Clinical Trials as Topi | 1999 |
[Hemolytic-uremic syndrome caused by mitomycin c: long-term management].
Topics: Antibiotics, Antineoplastic; Anus Neoplasms; Blood Pressure; Creatinine; Female; Follow-Up Studies; | 2000 |
[Hemolytic uremic syndrome--a serious complication of mitomycin treatment].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormon | 1997 |
Hemolytic uremic syndrome with intracranial hemorrhage following mitomycin C administration.
Topics: Alkylating Agents; Brain; Breast Neoplasms; Female; Hemolytic-Uremic Syndrome; Humans; Intracranial | 2001 |
Erythropoietin is beneficial in mitomycin-induced hemolytic-uremic syndrome.
Topics: Antibiotics, Antineoplastic; Colonic Neoplasms; Erythropoietin; Female; Hemolytic-Uremic Syndrome; H | 2002 |
[Chemotherapy-associated hemolytic uremic syndrome--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; | 1992 |
Cancer-associated hemolytic-uremic syndrome with spontaneous resolution. A case report.
Topics: Antineoplastic Agents; Female; Fluorouracil; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Mitomyc | 1991 |
Investigation of plasma von Willebrand factor and circulating platelet aggregating activity in mitomycin C-related hemolytic-uremic syndrome.
Topics: Blood Platelets; Hemolytic-Uremic Syndrome; Humans; Macromolecular Substances; Mitomycin; Mitomycins | 1990 |
Treatment of mitomycin-C-associated hemolytic uremic syndrome with plasmapheresis.
Topics: Adrenal Cortex Hormones; Adult; Combined Modality Therapy; Female; Hemolytic-Uremic Syndrome; Humans | 1990 |
[A case report of hemolytic uremic syndrome (HUS) induced by antineoplastic agents].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hemolytic-Uremic Syndrome; Humans; Mit | 1990 |
[Female with breast cancer, undergoing chemotherapeutic treatment hospitalized because of general deterioration, anemia and renal insufficiency].
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Mit | 1990 |
Successful treatment of mitomycin C-associated hemolytic uremic syndrome by plasmapheresis.
Topics: Adult; Female; Hemolytic-Uremic Syndrome; Humans; Kidney; Mitomycin; Mitomycins; Plasmapheresis | 1989 |
Cancer-associated hemolytic uremic syndrome: a possible role of mitomycin in relation to Shiga-like toxins.
Topics: Bacterial Toxins; Hemolytic-Uremic Syndrome; Humans; Mitomycin; Mitomycins; Shiga Toxin 2 | 1989 |
Hemolytic-uremic syndrome after cancer chemotherapy without mitomycin C.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hemolytic- | 1986 |
A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Female; Hemolytic-Uremic Syndrome; Humans; Hypoxia; | 1986 |
Drug-induced nephropathy: our recent clinical experience.
Topics: Adult; Aged; Carbon Tetrachloride; Female; Germanium; Hemolytic-Uremic Syndrome; Humans; Kidney Dise | 1986 |
Chronic glomerular microangiopathy complicating metastatic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Anemia, Hemolytic; Blood Coagulation; Chronic Disease; Female; Hemolyti | 1987 |
Haemolytic-uraemic syndrome associated with mitomycin-C treatment.
Topics: Female; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Mitomycin; Mitomycins | 1987 |
Mitomycin C associated hemolytic uremic syndrome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Doxorubicin; Fluorouracil; Hemolyti | 1987 |
[Anatomo-clinical conference. Hôpital de la Pitié-Salpêtrière. Case n. 2-1987. Anemia, thrombopenia and renal insufficiency in a patient treated for cancer of the pancreas].
Topics: Hemolytic-Uremic Syndrome; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Pancre | 1987 |
Mitomycin C-induced renal toxicity, a dose-dependent side effect?
Topics: Adult; Aged; Dose-Response Relationship, Drug; Female; Hemolysis; Hemolytic-Uremic Syndrome; Humans; | 1987 |
[Hemolytic-uremic syndrome caused by mitomycin C].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Hemolytic-Uremic Syndr | 1988 |
5-Fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evalu | 1988 |
Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
Topics: Acute Kidney Injury; Adenocarcinoma; Adult; Anemia, Hemolytic; Antibiotics, Antineoplastic; Antigen- | 1985 |
[Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Hemolytic-Uremic Syndro | 1985 |
[Nephrotoxicity of anti-tumor agents].
Topics: Antineoplastic Agents; Cisplatin; Dose-Response Relationship, Drug; Hemolytic-Uremic Syndrome; Human | 1985 |
Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Capillaries; Female; Glomerular Mesangium; Hemolytic-Uremi | 1985 |
Pulmonary angiomatoid vascular changes in mitomycin C-associated hemolytic-uremic syndrome.
Topics: Female; Hemolytic-Uremic Syndrome; Humans; Lung; Lung Diseases; Middle Aged; Mitomycin; Mitomycins; | 1985 |